Summary
Teradyne, Inc. reported a significant turnaround in its financial performance for the first quarter of 2010 compared to the same period in 2009. The company experienced a substantial increase in net revenues, driven primarily by a 269% surge in its Semiconductor Test segment, indicating a strong recovery in the semiconductor industry. This revenue growth, coupled with improved operational efficiencies and the benefits of earlier cost-reduction measures, resulted in a substantial swing from a net loss in Q1 2009 to a net income of $50.1 million in Q1 2010. Despite the strong revenue growth, the company's balance sheet shows a decrease in cash and cash equivalents, primarily due to significant investments in marketable securities and property, plant, and equipment. However, the company maintains a healthy liquidity position with $532.7 million in cash, cash equivalents, and marketable securities. Management expresses confidence that this balance will be sufficient to meet working capital and expenditure needs for at least the next twelve months.
Financial Highlights
26 data points| Revenue | $319.34M |
| Cost of Revenue | $149.46M |
| Gross Profit | $169.88M |
| SG&A Expenses | $54.69M |
| Operating Expenses | $110.88M |
| Operating Income | $58.99M |
| Interest Expense | $5.57M |
| Net Income | $50.10M |
| EPS (Basic) | $0.28 |
| EPS (Diluted) | $0.24 |
| Shares Outstanding (Basic) | 176.87M |
| Shares Outstanding (Diluted) | 226.28M |
Key Highlights
- 1Net revenues surged by 269% year-over-year to $329.6 million, primarily driven by a strong recovery in the Semiconductor Test segment.
- 2Teradyne swung from a net loss of $90.7 million in Q1 2009 to a net income of $50.1 million in Q1 2010.
- 3Gross profit margin improved significantly to 52.6% from 27.7% year-over-year, reflecting higher sales volume and operational efficiencies.
- 4The book-to-bill ratio for the total company was 1.6 for Q1 2010, indicating more orders were received than were billed, suggesting continued future revenue growth.
- 5Cash and cash equivalents decreased by $74.7 million during the quarter, mainly due to substantial investments in marketable securities ($95.4 million) and capital expenditures ($17.6 million).
- 6The company had $532.7 million in cash, cash equivalents, and marketable securities at the end of the quarter, providing ample liquidity.
- 7Restructuring charges decreased substantially from $20.2 million in Q1 2009 (allocated to segments) to $1.6 million in Q1 2010 for Semiconductor Test and $1.1 million for Systems Test Group, reflecting the completion of major restructuring efforts.